As SLE is an immunologically heterogeneous disease, and a strong association between CD8 cells and clinical findings has been demonstrated in some patients, we performed cluster analysis of patients with SLE based on differentiation phenotyping of peripheral CD8+ T cells and divided the patients into three subgroups (figure 3A). This evidence concerns the gene CD8A and systemic lupus erythematosus.